Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Comment by james700on Jul 24, 2020 2:30pm
64 Views
Post# 31315805

RE:james. one idea, dont bet 300 000$ on speculative small caps

RE:james. one idea, dont bet 300 000$ on speculative small caps
Seriously... I don't care about the $300k ... I can handle that just fine. The money used to buy shares by THOMVEST came from the FUTURE (repeat FUTURE) interest payments. When Prometic settled the loan in 2019, they paid THOMVEST all future 5 years of interest payments... That's not me Whining... That's me telling OTHER PEOPLE that these guys maneuver in SLICK ways. The interim CEO of the company negotiated the terms of the extended loan agreement. THEY DID NOT EVEN USE THEIR OWN MONEY TO BUY HALF OF THE SHARES THEY NOW CONTROL.... THINK ABOUT THAT!!! BEFORE YOU INVEST...
<< Previous
Bullboard Posts
Next >>